Survival analysis curves comparing the ICC patients with high and low ITGA3 expression in two patient cohorts showed that patients with relatively high ITGA3 expression (n = 32) had worse prognoses than those with lower ITGA3 expression (n = 14; P = 0.015; Figure 1(b)). Here, ITGA3 is linked to intrahepatic cholangiocarcinoma.